Pictet Asset Management (Switzerland)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $42.6M | Buy |
1,044,579
+104,083
| +11% | +$4.24M | 0.05% | 317 |
|
|
2023
Q1 | $35.1M | Buy |
940,496
+158,518
| +20% | +$5.91M | 0.04% | 347 |
|
|
2022
Q4 | $27.3M | Buy |
781,978
+15,816
| +2% | +$552K | 0.04% | 379 |
|
|
2022
Q3 | $42.9M | Buy |
766,162
+130,312
| +20% | +$7.29M | 0.06% | 290 |
|
|
2022
Q2 | $32.9M | Buy |
635,850
+269,317
| +73% | +$13.9M | 0.05% | 354 |
|
|
2022
Q1 | $26.6M | Sell |
366,533
-55,431
| -13% | -$4.03M | 0.03% | 436 |
|
|
2021
Q4 | $49.9M | Buy |
421,964
+166,740
| +65% | +$19.7M | 0.05% | 335 |
|
|
2021
Q3 | $34.2M | Buy |
+255,224
| New | +$34.2M | 0.04% | 404 |
|